Iranian Journal of Pediatrics

Published by: Kowsar

Immunosuppressive Therapy in Children With Steroid-Resistant Nephrotic Syndrome

Jing Li 1 , Qin Li 1 , Jinmiao Lu 1 and Zhiping Li 1 , *
Authors Information
1 Department of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China
Article information
  • Iranian Journal of Pediatrics: February 2018, 28 (1); e11567
  • Published Online: February 12, 2018
  • Article Type: Research Article
  • Received: April 1, 2017
  • Revised: July 29, 2017
  • Accepted: December 16, 2017
  • DOI: 10.5812/ijp.11567

To Cite: Li J, Li Q, Lu J, Li Z. Immunosuppressive Therapy in Children With Steroid-Resistant Nephrotic Syndrome, Iran J Pediatr. 2018 ;28(1):e11567. doi: 10.5812/ijp.11567.

Abstract
Copyright: Copyright © 2018, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Footnote
References
  • 1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362(9384):629-39.
  • 2. Hodson EM, Wong SC, Willis NS, Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev. 2016;10. CD003594. doi: 10.1002/14651858.CD003594.pub5. [PubMed: 27726125].
  • 3. Niaudet P, Boyer O. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. Springer Berlin Heidelberg; 2016. p. 667-702.
  • 4. Iijima K, Sako M, Nozu K. Rituximab for nephrotic syndrome in children. Clin Exp Nephrol. 2017;21(2):193-202. doi: 10.1007/s10157-016-1313-5. [PubMed: 27422620].
  • 5. Al Salloum AA, Muthanna A, Bassrawi R, Al Shehab AA, Al Ibrahim A, Islam MZ, et al. Long-term outcome of the difficult nephrotic syndrome in children. Saudi J Kidney Dis Transpl. 2012;23(5):965-72. doi: 10.4103/1319-2442.100877. [PubMed: 22982908].
  • 6. Internacional Study of Kidney Disease in Children . Nephrotic Syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 1978;13(2):159-65.
  • 7. Gipson DS, Chin H, Presler T. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21(3):344-9. doi: 10.1007/s00467-005-2097-0. [PubMed: 16395603].
  • 8. Sinha A, Bagga A. Nephrotic syndrome. Indian J Pediatr. 2012;79(8):1045-55. doi: 10.1007/s12098-012-0776-y. [PubMed: 22644544].
  • 9. Lombel RM, Hodson EM, Gipson DS, Kidney Disease: Improving Global O. Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol. 2013;28(3):409-14. doi: 10.1007/s00467-012-2304-8. [PubMed: 23052648].
  • 10. Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, et al. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Nephrology (Carlton). 2015;20(1):18-24. doi: 10.1111/nep.12351. [PubMed: 25312783].
  • 11. Moudgil A, Bagga A, Jordan SC. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. Pediatr Nephrol. 2005;20(10):1376-81.
  • 12. Li ZH, Lin Z, Duan CR, Wu TH, Xun M, Zhang Y, et al. [Comparison of therapeutic effects of prednisone combined with mycophenolate mofetil versus cyclosporin A in children with steroid-resistant nephrotic syndrome]. Zhongguo Dang Dai Er Ke Za Zhi. 2016;18(2):130-5. [PubMed: 26903059].
  • 13. Klaassen I, Ozgoren B, Sadowski CE, Moller K, van Husen M, Lehnhardt A, et al. Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible. Pediatr Nephrol. 2015;30(9):1477-83. doi: 10.1007/s00467-015-3109-3. [PubMed: 25903641].
  • 14. Straatmann C, Ayoob R, Gbadegesin R, Gibson K, Rheault MN, Srivastava T, et al. Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol. 2013;28(8):1235-41. doi: 10.1007/s00467-013-2483-y. [PubMed: 23633037].
  • 15. Basu B, Mahapatra TK, Mondal N. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome. Pediatrics. 2015;136(1):e132-9. doi: 10.1542/peds.2015-0486. [PubMed: 26101364].
  • 16. Li Z, Duan C, He J, Wu T, Xun M, Zhang Y, et al. Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2010;25(5):883-8. doi: 10.1007/s00467-009-1375-7. [PubMed: 19953275].
  • 17. Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol. 2009;24(8):1525-32. doi: 10.1007/s00467-009-1138-5. [PubMed: 19280229].
  • 18. Beins NT, Dell KM. Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors. Front Pediatr. 2015;3:104. doi: 10.3389/fped.2015.00104. [PubMed: 26640779].
  • 19. Sotelomundo RR. Chapter 4: Steroid-resistant nephrotic syndrome in children. Kidney Int Suppl (2011). 2012;2(2):172-6. doi: 10.1038/kisup.2012.17. [PubMed: 25018929].
  • 20. Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis. 2009;53(5):760-9. doi: 10.1053/j.ajkd.2008.11.033. [PubMed: 19268410].
  • 21. Peña A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, et al. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy. Pediatr Nephrol. 2007;22(11):1875-80.
  • 22. Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, et al. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2009;24(11):2177-85. doi: 10.1007/s00467-009-1264-0. [PubMed: 19714370].
  • 23. Cattran DC, Wang MM, Appel G, Matalon A, Briggs W. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol. 2004;62(6):405-11.
  • 24. Diamond PH, Gruzinov AV. Immunosupressive therapy in children with steroid-resistant nephrotic syndrome: single center experience. J Bras Nefrol. 2013;35(3):200-5. doi: 10.5935/0101-2800.20130032. [PubMed: 24100739].
  • 25. Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr Nephrol. 2005;20(4):482-5.
  • 26. Tsutsumi Y, Kanamori H, Mori A. Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf. 2005;4(3):599-608. doi: 10.1517/14740338.4.3.599. [PubMed: 15934864].
  • 27. Boren EJ, Cheema GS, Naguwa SM. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun. 2008;30(1-2):90-8. doi: 10.1016/j.jaut.2007.11.013. [PubMed: 18191544].
  • 28. Ardelean DS, Gonska T, Wires S, Cutz E, Griffiths A, Harvey E, et al. Severe ulcerative colitis after rituximab therapy. Pediatrics. 2010;126(1):e243-6. doi: 10.1542/peds.2009-3395. [PubMed: 20566611].
  • 29. Ahn YH, Kang HG, Lee JM, Choi HJ, Ha IS, Cheong HI. Development of antirituximab antibodies in children with nephrotic syndrome. Pediatr Nephrol. 2014;29(8):1461-4. doi: 10.1007/s00467-014-2794-7. [PubMed: 24619426].
  • 30. Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children. Pediatr Nephrol. 2016;31(3):425-34. doi: 10.1007/s00467-015-3174-7. [PubMed: 26335197].
  • 31. Hjorten R, Anwar Z, Reidy KJ. Long-term Outcomes of Childhood Onset Nephrotic Syndrome. Front Pediatr. 2016;4:53. doi: 10.3389/fped.2016.00053. [PubMed: 27252935].
  • 32. Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, et al. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol. Pediatr Int. 2015;57(1):85-91. doi: 10.1111/ped.12498. [PubMed: 25225083].
  • 33. Colquitt J, Kirby J, Green C. The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Health Technol Assess. 2007;11(21):1-93.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader